965 related articles for article (PubMed ID: 11817980)
21. Review of zolmitriptan and its clinical applications in migraine.
Dowson AJ; Charlesworth B
Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
[TBL] [Abstract][Full Text] [Related]
22. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
23. Almotriptan, a new anti-migraine agent: a review.
Gras J; Llenas J; Jansat JM; Jáuregui J; Cabarrocas X; Palacios JM
CNS Drug Rev; 2002; 8(3):217-34. PubMed ID: 12353056
[TBL] [Abstract][Full Text] [Related]
24. A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
Dodick DW
Expert Opin Pharmacother; 2003 Jul; 4(7):1157-63. PubMed ID: 12831340
[TBL] [Abstract][Full Text] [Related]
25. Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.
Cady R
Headache; 2002 Jan; 42 Suppl 1():26-31. PubMed ID: 11966861
[TBL] [Abstract][Full Text] [Related]
26. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
Dowson AJ; Massiou H; Laínez JM; Cabarrocas X
Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
[TBL] [Abstract][Full Text] [Related]
27. How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
Dahlöf CG; Dodick D; Dowson AJ; Pascual J
Headache; 2002 Feb; 42(2):99-113. PubMed ID: 12005302
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of almotriptan in controlled clinical trials.
Mathew NT
Eur Neurol; 2005; 53 Suppl 1():29-33. PubMed ID: 15920335
[TBL] [Abstract][Full Text] [Related]
29. Early intervention with almotriptan improves sustained pain-free response in acute migraine.
Mathew NT
Headache; 2003; 43(10):1075-9. PubMed ID: 14629242
[TBL] [Abstract][Full Text] [Related]
30. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
31. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
32. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of subcutaneous almotriptan for the treatment of acute migraine: a randomized, double-blind, parallel-group, dose-finding study.
Cabarrocas X;
Clin Ther; 2001 Nov; 23(11):1867-75. PubMed ID: 11768838
[TBL] [Abstract][Full Text] [Related]
34. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
35. Comparative tolerability of treatments for acute migraine: A network meta-analysis.
Thorlund K; Toor K; Wu P; Chan K; Druyts E; Ramos E; Bhambri R; Donnet A; Stark R; Goadsby PJ
Cephalalgia; 2017 Sep; 37(10):965-978. PubMed ID: 27521843
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
Linder SL; Mathew NT; Cady RK; Finlayson G; Ishkanian G; Lewis DW
Headache; 2008 Oct; 48(9):1326-36. PubMed ID: 18484981
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
38. Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
Von S
Am J Manag Care; 2002 Feb; 8(3 Suppl):S74-9. PubMed ID: 11859907
[TBL] [Abstract][Full Text] [Related]
39. Almotriptan: pharmacological differences and clinical results.
Pascual J
Curr Med Res Opin; 2001; 17 Suppl 1():s63-7. PubMed ID: 12463281
[TBL] [Abstract][Full Text] [Related]
40. Eletriptan: a review of its use in the acute treatment of migraine.
McCormack PL; Keating GM
Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
